Related projects
Discover more projects across a range of sectors and discipline — from AI to cleantech to social innovation.
Parkinson’s disease is commonly described as a brain disorder, but recent research suggests that early events outside the brain (periphery) may influence Parkinson’s disease neuropathology. The blood-brain barrier is a structure that protects the vulnerable brain tissue from blood-borne toxins and circulating immune cells, but barrier function appears compromised in PD. A consequence, there may be increased entry of toxic peripheral elements and immune cells intro the brain, and these peripheral factors could reach brain cells and possibly accelerate disease progression. Astrocytes, crucial for BBB maintenance, become impaired in Parkinson’s disease, further weakening this barrier. A new 3D brain-chip model built using induced pluripotent stem cells enables detailed study of these interactions. This model allows researchers to observe how astrocytes and peripheral immune cells contribute to blood-brain barrier dysfunction, and the subsequent entry of potentially toxic elements into the brain. The proposed research will help define the role of the brain-periphery immune axis, which could uncover new targets to slow Parkinson’s disease progression, offering hope for disease-modifying therapies.
Aurelie de Rus Jacquet
Sorbonne Université
Life Sciences
Health and Related Sciences & Technology; Biotechnology
Université Laval
Globalink Research Award
Discover more projects across a range of sectors and discipline — from AI to cleantech to social innovation.
Find the perfect opportunity to put your academic skills and knowledge into practice!
Find ProjectsThe strong support from governments across Canada, international partners, universities, colleges, companies, and community organizations has enabled Mitacs to focus on the core idea that talent and partnerships power innovation — and innovation creates a better future.